Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Apr;44(2):395-402.
doi: 10.1177/0300060515595651. Epub 2016 Jan 25.

Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32.2q33.1

Affiliations
Case Reports

Specific behavioural phenotype and secondary cognitive decline as a result of an 8.6 Mb deletion of 2q32.2q33.1

Hojka Gregoric Kumperscak et al. J Int Med Res. 2016 Apr.

Abstract

Chromosomal abnormalities involving 2q32q33 deletions are very rare and present with a specific phenotype. This case report describes a 37-year-old female patient with 2q32q33 microdeletion syndrome presenting with the characteristic features, but with the addition of secondary cognitive decline. Molecular karyotyping was performed on the patient and her parents. It revealed an 8.6 megabase deletion with the proximal breakpoint in the chromosome band 2q32.2 and the distal breakpoint in 2q33.1. The deletion encompassed 22 known genes, including theGLS,MYO1B,TMEFF2,PGAP1andSATB2genes. The observed deletion was confirmed using a paralogue ratio test. This case report provides further evidence that theSATB2gene, together withGLS,MYO1B,TMEFF2and possiblyPGAP1,is a crucial gene in 2q32q33 microdeletion syndrome. TheSATB2gene seems to be crucial for the behavioural problems noted in our case, but deletion of theGLS,MYO1BandTMEFF2genes presumably contributed to the more complex behavioural characteristics observed. Our patient is also, to our knowledge, the only patient with 2q32q33 microdeletion syndrome with secondary cognitive decline.

Keywords: 2q32q33 microdeletion syndrome; SATB2 gene; behavioural problems; developmental delay; secondary cognitive decline.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Current appearance of a 37-year-old woman with a de novo 8.6 megabase deletion of 2q32.2q33.1 who presented with the characteristic phenotype and behavioural problems, but who also experienced prominent secondary cognitive decline. Characteristic features of 2q32q33 microdeletion syndrome noted in this patient are the sparse hair, thin, pale skin and craniofacial dysmorphism (including long and asymmetric face, short and flat philtrum, pointed chin, oligodontia, and periorbital dermoid cyst). The colour version of this figure is available at: http://imr.sagepub.com.
Figure 2.
Figure 2.
A schematic presentation of deletions in patients with reported 2q32q33 microdeletion syndrome and behavioural problems, including those of the present case (labelled red). Size and positions of deletions with implicated genes are presented in the University of California, Santa Cruz Genome Browser. The colour version of this figure is available at: http://imr.sagepub.com.

Similar articles

Cited by

References

    1. Balasubramanian M, Smith K, Basel-Vanagaite L, et al. Case series: 2q33.1 microdeletion syndrome–further delineation of the phenotype. J Med Genet 2011; 48: 290–298. - PubMed
    1. Online Mendelian Inheritance in Man®. An Online Catalog of Human Genes and Genetic Disorders. Glass syndrome, http://www.omim.org/entry/612313 (1995, accessed 21 May 2015).
    1. Vogels A, Haegeman J, Fryns JP. Pierre-Robin sequence and severe mental retardation with chaotic behaviour associated with a small interstitial deletion in the long arm of chromosome 2 (del(2)(q331q333)). Genet Couns 1997; 8: 249–252. - PubMed
    1. Van Buggenhout G, Van Ravenswaaij-Arts C, Mc Maas N, et al. The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients. Eur J Med Genet 2005; 48: 276–289. - PubMed
    1. Mencarelli MA, Caselli R, Pescucci C, et al. Clinical and molecular characterization of a patient with a 2q31.2-32.3 deletion identified by array-CGH. Am J Med Genet A 2007; 143A: 858–865. - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources